Covaxin gets emergency use recommendation for children aged 2-18 years
The subject expert committee on Covid-19 vaccines has recommended the national drug regulator to grant an emergency use authorisation to Bharat Biotech’s Covaxin for the age group of 2 to 18 years, health ministry sources said. The development is significant as India is just one step away from a Covid-19 vaccine…